{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:21:52Z","timestamp":1778617312437,"version":"3.51.4"},"reference-count":56,"publisher":"Impact Journals, LLC","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2023,11,30]]},"DOI":"10.18632\/aging.205211","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T19:25:21Z","timestamp":1700076321000},"page":"12927-12951","source":"Crossref","is-referenced-by-count":8,"title":["A novel telomere-related genes model for predicting prognosis and treatment responsiveness in diffuse large B-cell lymphoma"],"prefix":"10.18632","volume":"15","author":[{"given":"Zhijia","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Hematology, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochen","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siqi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqin","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.","volume":"40","author":"Marti","year":"2000","journal-title":"Nature"},{"key":"2","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1158\/2159-8290.CD-20-0174","article-title":"Toward a New Molecular Taxonomy of Diffuse Large B-cell Lymphoma.","volume":"1","author":"Scott","year":"2020","journal-title":"Cancer Discov"},{"key":"3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/13543784.2021.1855140","article-title":"Investigational drugs for the treatment of diffuse large B-cell lymphoma.","volume":"3","author":"Gaidano","year":"2021","journal-title":"Expert Opin Investig Drugs"},{"key":"4","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1182\/bloodadvances.2021004618","article-title":"A germinal center-associated microenvironmental signature reflects malignant phenotype and outcome of DLBCL.","volume":"6","author":"Aster","year":"2022","journal-title":"Blood Adv"},{"key":"5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s12185-009-0353-y","article-title":"Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab.","volume":"9","author":"Nola","year":"2009","journal-title":"Int J Hematol"},{"key":"6","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1182\/blood-2006-09-047068","article-title":"Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy.","volume":"10","author":"Lepp\u00e4","year":"2007","journal-title":"Blood"},{"key":"7","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1038\/s41375-021-01285-3","article-title":"Treatment resistance in diffuse large B-cell lymphoma.","volume":"3","author":"Kridel","year":"2021","journal-title":"Leukemia"},{"key":"8","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma.","volume":"32","author":"International Non-Hodgkin's Lymphoma Prognostic Factors Project","year":"1993","journal-title":"N Engl J Med"},{"key":"9","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/nm1006-1133","article-title":"Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging.","volume":"1","author":"Szostak","year":"2006","journal-title":"Nat Med"},{"key":"10","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41586-021-03415-4","article-title":"Structure of human telomerase holoenzyme with bound telomeric DNA.","volume":"59","author":"Nguyen","year":"2021","journal-title":"Nature"},{"key":"11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/cancers10060169","article-title":"The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical Outcomes.","volume":"1","author":"Heidingsfelder","year":"2018","journal-title":"Cancers (Basel)"},{"key":"12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41576-019-0099-1","article-title":"Telomeres and telomerase: three decades of progress.","volume":"2","author":"Wright","year":"2019","journal-title":"Nat Rev Genet"},{"key":"13","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.3390\/biomedicines10092299","article-title":"Consecutive Inhibition of Telomerase and Alternative Lengthening Pathway Promotes Hodgkin's Lymphoma Cell Death.","volume":"1","author":"Mai","year":"2022","journal-title":"Biomedicines"},{"key":"14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41568-022-00490-1","article-title":"Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.","volume":"2","author":"Pickett","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12863-018-0617-8","article-title":"TelNet - a database for human and yeast genes involved in telomere maintenance.","volume":"1","author":"Rippe","year":"2018","journal-title":"BMC Genet"},{"key":"16","doi-asserted-by":"publisher","first-page":"e0281037","DOI":"10.1371\/journal.pone.0281037","article-title":"Developmental changes in straight gait in childhood.","volume":"1","author":"Kozuka","year":"2023","journal-title":"PLoS One"},{"key":"17","doi-asserted-by":"publisher","first-page":"e0009776","DOI":"10.1371\/journal.pntd.0009776","article-title":"The association between tropical cyclones and dengue fever in the Pearl River Delta, China during 2013-2018: A time-stratified case-crossover study.","volume":"1","author":"Ma","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"18","first-page":"837","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.","volume":"4","author":"Clarke-Pearson","year":"1988","journal-title":"Biometrics"},{"key":"19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.transci.2007.04.006","article-title":"Telomeres and telomerase in leukaemia and lymphoma.","volume":"3","author":"Davison","year":"2007","journal-title":"Transfus Apher Sci"},{"key":"20","doi-asserted-by":"publisher","first-page":"2308249","DOI":"10.1155\/2016\/2308249","article-title":"Commonalities in the Association between PPARG and Vitamin D Related with Obesity and Carcinogenesis.","volume":"201","author":"Mac\u00edas-Gonz\u00e1lez","year":"2016","journal-title":"PPAR Res"},{"key":"21","doi-asserted-by":"publisher","first-page":"624112","DOI":"10.3389\/fendo.2021.624112","article-title":"PPARgamma in Metabolism, Immunity, and Cancer: Unified and Diverse Mechanisms of Action.","volume":"1","author":"Kalkhoven","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41467-017-00147-w","article-title":"Evasion of immunosurveillance by genomic alterations of PPAR\u03b3\/RXR\u03b1 in bladder cancer.","volume":"8","author":"Tortora","year":"2017","journal-title":"Nat Commun"},{"key":"23","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1093\/carcin\/bgl013","article-title":"Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.","volume":"2","author":"Rothman","year":"2006","journal-title":"Carcinogenesis"},{"key":"24","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1182\/blood.2020005602","article-title":"Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment.","volume":"13","author":"Hill","year":"2020","journal-title":"Blood"},{"key":"25","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.3390\/cancers13112717","article-title":"Advances in the Pathogenesis of EBV-Associated Diffuse Large B Cell Lymphoma.","volume":"1","author":"Chabay","year":"2021","journal-title":"Cancers (Basel)"},{"key":"26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/med.20211","article-title":"Telomere\/telomerase interplay in virus-driven and virus-independent lymphomagenesis: pathogenic and clinical implications.","volume":"3","author":"De Rossi","year":"2012","journal-title":"Med Res Rev"},{"key":"27","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1182\/blood-2016-02-702530","article-title":"Regulation of EBV LMP1-triggered EphA4 downregulation in EBV-associated B lymphoma and its impact on patients' survival.","volume":"12","author":"Tsai","year":"2016","journal-title":"Blood"},{"key":"28","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1158\/0008-5472.CAN-04-1253","article-title":"Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in S\u00e9zary syndrome identified by gene expression analysis.","volume":"6","author":"Tensen","year":"2004","journal-title":"Cancer Res"},{"key":"29","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1038\/s41467-022-30409-1","article-title":"TUBB4A interacts with MYH9 to protect the nucleus during cell migration and promotes prostate cancer via GSK3\u03b2\/\u03b2-catenin signalling.","volume":"1","author":"Bae","year":"2022","journal-title":"Nat Commun"},{"key":"30","doi-asserted-by":"publisher","first-page":"666199","DOI":"10.3389\/fonc.2021.666199","article-title":"Prognostic Implication of a Novel Metabolism-Related Gene Signature in Hepatocellular Carcinoma.","volume":"1","author":"Cheng","year":"2021","journal-title":"Front Oncol"},{"key":"31","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/onc.2009.431","article-title":"TCEAL7, a putative tumor suppressor gene, negatively regulates NF-kappaB pathway.","volume":"2","author":"Shridhar","year":"2010","journal-title":"Oncogene"},{"key":"32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1593\/neo.10180","article-title":"TCEAL7 inhibition of c-Myc activity in alternative lengthening of telomeres regulates hTERT expression.","volume":"1","author":"Keith","year":"2010","journal-title":"Neoplasia"},{"key":"33","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3390\/cancers15030737","article-title":"The NOTCH-RIPK4-IRF6-ELOVL4 Axis Suppresses Squamous Cell Carcinoma.","volume":"1","author":"Schramek","year":"2023","journal-title":"Cancers (Basel)"},{"key":"34","doi-asserted-by":"publisher","first-page":"5741","DOI":"10.1038\/s41388-021-01959-3","article-title":"The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome.","volume":"4","author":"Agostini","year":"2021","journal-title":"Oncogene"},{"key":"35","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.21037\/tcr-22-761","article-title":"The prognostic role of fatty acid metabolism-related genes in patients with gastric cancer.","volume":"1","author":"Xu","year":"2022","journal-title":"Transl Cancer Res"},{"key":"36","doi-asserted-by":"publisher","first-page":"6557","DOI":"10.2147\/JIR.S340119","article-title":"ARL14 as a Prognostic Biomarker in Non-Small Cell Lung Cancer.","volume":"1","author":"Wang","year":"2021","journal-title":"J Inflamm Res"},{"key":"37","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s10238-022-00867-4","article-title":"Clinical significance of circulating neutrophils and lymphocyte subsets in newly diagnosed patients with diffuse large B-cell lymphoma.","volume":"2","author":"Yu","year":"2023","journal-title":"Clin Exp Med"},{"key":"38","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1172\/JCI80005","article-title":"Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected.","volume":"12","author":"Gabrilovich","year":"2015","journal-title":"J Clin Invest"},{"key":"39","doi-asserted-by":"publisher","first-page":"14381","DOI":"10.1038\/ncomms14381","article-title":"Neutrophils dominate the immune cell composition in non-small cell lung cancer.","volume":"8","author":"Houghton","year":"2017","journal-title":"Nat Commun"},{"key":"40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s43018-023-00521-2","article-title":"CD4T cells in cancer.","volume":"4","author":"M\u00fcnz","year":"2023","journal-title":"Nat Cancer"},{"key":"41","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41568-019-0153-5","article-title":"\u03b3\u03b4 T cells: pleiotropic immune effectors with therapeutic potential in cancer.","volume":"1","author":"Coffelt","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"42","doi-asserted-by":"publisher","first-page":"1140623","DOI":"10.3389\/fimmu.2023.1140623","article-title":"A close look at current \u03b3\u03b4 T-cell immunotherapy.","volume":"1","author":"Zhou","year":"2023","journal-title":"Front Immunol"},{"key":"43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-018-0928-4","article-title":"Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape.","volume":"1","author":"Xiong","year":"2019","journal-title":"Mol Cancer"},{"key":"44","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.","volume":"54","author":"Weissman","year":"2017","journal-title":"Nature"},{"key":"45","doi-asserted-by":"publisher","first-page":"319","DOI":"10.15698\/cst2019.10.201","article-title":"Inflammation induced PD-L1-specific T cells.","volume":"3","author":"Andersen","year":"2019","journal-title":"Cell Stress"},{"key":"46","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s11899-020-00589-y","article-title":"PD-1\/PD-L1 Pathway and Its Blockade in Patients with Classic Hodgkin Lymphoma and Non-Hodgkin Large-Cell Lymphomas.","volume":"1","author":"Xu","year":"2020","journal-title":"Curr Hematol Malig Rep"},{"key":"47","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3.","volume":"9","author":"Jove","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"48","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1089\/jir.2015.0054","article-title":"STAT5 in Cancer and Immunity.","volume":"3","author":"Murphy","year":"2016","journal-title":"J Interferon Cytokine Res"},{"key":"49","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1038\/s41467-018-06134-z","article-title":"STAT3-coordinated migration facilitates the dissemination of diffuse large B-cell lymphomas.","volume":"9","author":"Yang","year":"2018","journal-title":"Nat Commun"},{"key":"50","doi-asserted-by":"publisher","first-page":"43881","DOI":"10.18632\/oncotarget.6316","article-title":"Cerdulatinib, a novel dual SYK\/JAK kinase inhibitor, has broad anti-tumor activity in both ABC and GCB types of diffuse large B cell lymphoma.","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"51","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1200\/JCO.2010.31.1142","article-title":"Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.","volume":"2","author":"Leonard","year":"2011","journal-title":"J Clin Oncol"},{"key":"52","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1365-2141.2006.06210.x","article-title":"Mammalian target of rapamycin inhibition induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitises DLBCL cells to rituximab.","volume":"13","author":"Decker","year":"2006","journal-title":"Br J Haematol"},{"key":"53","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1182\/blood-2011-03-340109","article-title":"The novel anti-MEK small molecule AZD6244 induces BIM-dependent and AKT-independent apoptosis in diffuse large B-cell lymphoma.","volume":"11","author":"Gartenhaus","year":"2011","journal-title":"Blood"},{"key":"54","doi-asserted-by":"publisher","first-page":"7635","DOI":"10.1158\/0008-5472.CAN-09-0511","article-title":"Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitro.","volume":"6","author":"Kaufmann","year":"2009","journal-title":"Cancer Res"},{"key":"55","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00280-009-1232-1","article-title":"The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo.","volume":"6","author":"Shoemaker","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"56","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1200\/JCO.2010.28.1618","article-title":"Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era.","volume":"2","author":"Schmitz","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T14:33:10Z","timestamp":1701873190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":56,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2023,11,30]]}},"alternative-id":["205211","37976136"],"URL":"https:\/\/doi.org\/10.18632\/aging.205211","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]}}}